AI
Wednesday, March 06, 2013 6:56:27 PM
If XNPT's drug (829) were further along it may fit the bill then they would be fighting with Biogen again in the oral space 
. Still I would think it may be a tad less than 6-7, maybe 3-4 , if they could go the 505 route. I sold my position last year so haven't kept up.
. Still I would think it may be a tad less than 6-7, maybe 3-4 , if they could go the 505 route. I sold my position last year so haven't kept up.
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
